This website uses cookies to enhance the user experience.
B

BLÅ BIOTEK AS914 211 077

Research
Limited company
Daugstadvegen 445 6392 VIKEBUKT, Norge

BLÅ BIOTEK AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
Chairman of the board
Years since formation
10 years
since Sep 26, 2014
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
150
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Annual total result 2023
-85,758
NOK
Total equity 2023
-311,273
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
indirectly

Board

NameRoleShares
Chairman
100 %
indirectly
Board Member-

Others

NameRoleShares
P
PRAVDA ACCOUNTING AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
indirectly
Last update: Jan 10, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
A
AKVAPROSJEKTER AS
Ordinary shares
150
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -8,728
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-85,758
-6,768
-10,363
Total assets
405
4,611
8,053
Total liabilities
311,678
230,126
226,800
Total equity
-311,273
-225,515
-218,746

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
85,758
6,768
10,363
Operating result
-85,758
-6,768
-10,363
Financial income/costs
0
0
0
Profit before tax
-85,758
-6,768
-10,363
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-85,758
-6,768
-10,363

Balance overview

Year202320222021
Total fixed assets
0
0
0
Total current assets
405
4,611
8,053
Total assets
405
4,611
8,053
Short term debt
5,937
5,563
226,800
Long term debt
305,741
224,562
0
Total liabilities
311,678
230,126
226,800
Contributed capital
139,584
139,584
139,584
Retained earnings
-450,857
-365,099
-358,330
Total equity
-311,273
-225,515
-218,746
Total equity and liabilities
405
4,611
8,053

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology